• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: W.L. GORE & ASSOCIATES GORE® VIABAHN® ENDOPROSTHESIS; NIP

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

W.L. GORE & ASSOCIATES GORE® VIABAHN® ENDOPROSTHESIS; NIP Back to Search Results
Device Problem Complete Blockage (1094)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Date 10/26/2015
Event Type  Injury  
Manufacturer Narrative
(b)(4).No testing methods were performed since no product information was available.
 
Event Description
In review of published literature, these findings were noted: hung-lung hsu, chen-ming huang, yin-yin chen, fu-chien hsieh,and jer-shen chen, ¿the sandwich technique with body flossing wire to revascularize left subclavian artery in thoracic endovascular aortic repair¿, annals of vascular surgery 2017; 39: 152¿159, http://dx.Doi.Org/10.1016/j.Avsg.2016.04.016.From april 2014 to april 2015, 20 consecutive patients (14 males and 6 females, mean age 61.4) receiving tevar for acute or chronic thoracic aortic pathologies which need covering the lsa for adequate proximal landing were included.All patients were implanted with gore® viabahn® endoprosthesis in the left subclavian artery as periscope grafts, 15 patients with only one graft and five patients with more than one graft.Seven of 20 patients were implanted with gore® viabahn® endoprosthesis in the left common carotid artery (lcca) as chimney endografts.Total 19 patients had patent sandwiched grafts.It was stated that the patency rate of the sandwiched periscope graft in the thoracic aorta was 95% at a mean follow-up of 9.7 months.The only one (5%) occluded sandwiched periscope graft was found in a (b)(6) female with chronic sternal wound infection and rapid expansion of residual descending aortic dissection at 12-month follow-up after reintervention for a type ia endoleak.This lsa graft might be compressed or kinked during the secondary procedure by the kissing balloon technique over the lcca chimney graft and the extended proximal aortic endograft.No neurological deficit or left upper limb ischemia was noted in the patient and the occluded graft was not addressed.
 
Manufacturer Narrative
Add the literuture as attachment.(b)(4) additional information about this event was requested but could not be obtained.Without additional information it is impossible to further investigate this event.(b)(4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
GORE® VIABAHN® ENDOPROSTHESIS
Type of Device
NIP
Manufacturer (Section D)
W.L. GORE & ASSOCIATES
flagstaff AZ
Manufacturer (Section G)
MEDICAL ECHO RIDGE B/P
3250 w. kiltie lane
flagstaff AZ 86005
Manufacturer Contact
helen huang
1500 n. 4th street
flagstaff, AZ 
9285263030
MDR Report Key6939712
MDR Text Key89223255
Report Number2017233-2017-00534
Device Sequence Number1
Product Code PFV
Combination Product (y/n)N
Reporter Country CodeTW
PMA/PMN Number
P040037
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,study
Reporter Occupation Physician
Type of Report Initial,Followup,Followup
Report Date 11/23/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received Not provided
Initial Date FDA Received10/11/2017
Supplement Dates Manufacturer ReceivedNot provided
Not provided
Supplement Dates FDA Received10/30/2017
11/23/2017
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other;
Patient Age70 YR
-
-